All recorded activity
- Rounds participated in
- 1
- Confirmed lead rounds
- 0
All roles disclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $7M
1 disclosed · full round size, not this investor’s share
Rounds
1 in all activitySenticellSenticell is developing a liquid-biopsy diagnostic based on nucleic acids associated with red blood cells.
Participant